Division of Maternal-Fetal Medicine and the Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences, the Cardiovascular Institute of New Jersey, and the Department of Medicine, Rutgers Robert Wood Johnson Medical School, New Brunswick, and the Department of Biostatistics and Epidemiology, Rutgers School of Public Health, Piscataway, New Jersey; the Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, NYU Langone Health, New York, New York; and the Clinical Epidemiology Division, Faculty of Medicine at Solna, Karolinska Institutet, Stockholm, Sweden.

Corresponding author: Cande V. Ananth, PhD, MPH, Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ; [email protected]

Dr. Ananth and Ms. Lee are supported by the National Heart, Lung, and Blood Institute (grant R01-HL150065); Dr. Ananth is also supported by the National Institute of Environmental Health Sciences (grant R01-ES033190), the National Institutes of Health.

Financial Disclosure The authors did not report any potential conflicts of interest.

Presented as a poster at the Society for Maternal-Fetal Medicine’s 42nd Annual Pregnancy Meeting, held virtually, January 31–February 5, 2022.

Each author has confirmed compliance with the journal's requirements for authorship.

Peer reviews and author correspondence are available at https://links.lww.com/AOG/D468.